Literature DB >> 20456956

Fewer fractions of adjuvant external beam radiotherapy for early breast cancer are safe and effective and can now be the standard of care. Why the UK's NICE accepts fewer fractions as the standard of care for adjuvant radiotherapy in early breast cancer.

Adrian Harnett1.   

Abstract

Fractionation regimes for individual tumour sites have varied greatly across the UK for many years. This has been particularly true for breast cancer which accounts for up to 40% of a radiotherapy department's work load. Over the last 30 years or so many UK oncology centres have coped with this large case load and a lack of megavoltage machines by reducing fractionation and routinely using internationally non standard regimes so that these regimes have themselves become one of the options for standard treatment. Nowadays, medicine is largely evidence based rather than historically relying more on clinical experience or intuition. Large studies particularly in the UK and Canada set out to address this question and have shown that fewer fractions are equivalent in terms of local recurrence, late tissue effects and cosmesis. Current studies are focusing on further hypofractionation and partial breast radiotherapy (see papers Yarnold (2010) Is it safe to push "hypofractionation" further?. The Breast (this issue). Lehman (2010) The less than whole breast radiotherapy approach. The Breast (this issue)). Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20456956     DOI: 10.1016/j.breast.2010.03.029

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  16 in total

1.  AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.

Authors:  Christoph Thomssen; Anton Scharl; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2011-08-30       Impact factor: 2.860

2.  Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of tomotherapy (TomoDirect): a prospective phase II trial.

Authors:  Pierfrancesco Franco; Michele Zeverino; Fernanda Migliaccio; Domenico Cante; Piera Sciacero; Valeria Casanova Borca; Paolo Torielli; Cecilia Arrichiello; Giuseppe Girelli; Maria Rosa La Porta; Santi Tofani; Gianmauro Numico; Umberto Ricardi
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-30       Impact factor: 4.553

Review 3.  Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence.

Authors:  Pierfrancesco Franco; Domenico Cante; Piera Sciacero; Giuseppe Girelli; Maria Rosa La Porta; Umberto Ricardi
Journal:  Breast Care (Basel)       Date:  2015-02       Impact factor: 2.860

4.  Hypofractionation and concomitant boost to deliver adjuvant whole-breast radiation in ductal carcinoma in situ (DCIS): a subgroup analysis of a prospective case series.

Authors:  Domenico Cante; Pierfrancesco Franco; Piera Sciacero; Giuseppe Girelli; Anna Maria Marra; Massimo Pasquino; Giuliana Russo; Valeria Casanova Borca; Guido Mondini; Ovidio Paino; Gianmauro Numico; Santi Tofani; Maria Rosa La Porta; Umberto Ricardi
Journal:  Med Oncol       Date:  2014-01-12       Impact factor: 3.064

5.  Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

Authors:  R Kreienberg; U-S Albert; M Follmann; I B Kopp; T Kühn; A Wöckel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-06       Impact factor: 2.915

6.  Do hypofraction and large breast size reciprocally fit in breast cancer radiotherapy?

Authors:  Pierfrancesco Franco; Sara Bartoncini; Stefania Martini; Giuseppe Carlo Iorio; Umberto Ricardi
Journal:  Ann Transl Med       Date:  2019-07

7.  Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.

Authors:  Cameron W Swanick; Xiudong Lei; Simona F Shaitelman; Pamela J Schlembach; Elizabeth S Bloom; Michelle C Fingeret; Eric A Strom; Welela Tereffe; Wendy A Woodward; Michael C Stauder; Tomas Dvorak; Alastair M Thompson; Thomas A Buchholz; Benjamin D Smith
Journal:  Cancer       Date:  2016-06-15       Impact factor: 6.860

8.  Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.

Authors:  Francesca Arcadipane; Pierfrancesco Franco; Chiara De Colle; Nadia Rondi; Jacopo Di Muzio; Emanuela Pelle; Stefania Martini; Ada Ala; Mario Airoldi; Michela Donadio; Corrado De Sanctis; Isabella Castellano; Riccardo Ragona; Umberto Ricardi
Journal:  Med Oncol       Date:  2016-08-29       Impact factor: 3.064

9.  Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.

Authors:  Justin E Bekelman; Gosia Sylwestrzak; John Barron; Jinan Liu; Andrew J Epstein; Gary Freedman; Jennifer Malin; Ezekiel J Emanuel
Journal:  JAMA       Date:  2014-12-17       Impact factor: 56.272

10.  Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer.

Authors:  Domenico Cante; Pierfrancesco Franco; Piera Sciacero; Giuseppe Girelli; Anna Maria Marra; Massimo Pasquino; Giuliana Russo; Valeria Casanova Borca; Guido Mondini; Ovidio Paino; Roberto Barmasse; Santi Tofani; Gianmauro Numico; Maria Rosa La Porta; Umberto Ricardi
Journal:  Med Oncol       Date:  2013-03-05       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.